De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients (clinicaltrials.gov) - Oct 16, 2025 - P3 | N=60 | Recruiting | Sponsor: Virginia Commonwealth University | Trial primary completion date: Sep 2025 ➔ Dec 2025
Trial primary completion date • Cytomegalovirus Infection • Transplantation • CYP3A5
|